What is aTyr Pharma's current ratio?

aTyr Pharma (ATYR) reported current ratio of 5.8× in Q1 2026.

How has aTyr Pharma's current ratio changed year-over-year?

aTyr Pharma's current ratio decreased by 25.9% year-over-year, from 7.8× to 5.8×.

What is the long-term trend for aTyr Pharma's current ratio?

Over 5 years (2020 to 2025), aTyr Pharma's current ratio has grown at a -2.7% compound annual growth rate (CAGR), from 6.1× to 5.3×.

What does current ratio mean?

Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.

aTyr Pharma ATYR Current ratio

Current ratio at other companies

Bristol-Myers SquibbBMY

1.4×+0.1×

Merck & Co.MRK

1.3×-0.1×

United TherapeuticsUTHR

4.8×-0.7×

Design Therapeutics, Inc.DSGN

22.3×-6.1×

Oric Pharmaceuticals, Inc.ORIC

16.3×+4.3×

Vor BiopharmaVOR

31.1×+27.3×

Other financials

Income statement

See full

Revenue-—

Operating income-$11.4M+27.5%

Net income-$10.8M+27.5%

EPS (diluted)-$0.11+35.3%

Balance sheet

See full

Cash & equivalents$10.0M-3.4%

Total debt$12.3M-9.2%

Total equity$57.9M-22.8%

Total assets$79.7M-18.1%

Cash flow

See full

Operating cash flow-$12.5M+18.8%

CapEx$138.0K—

Free cash flow-$12.7M+17.9%

Valuation

See full

Market cap$54.88M-88.2%

Enterprise value$57.17M—

P/S288.8×—

Profitability

See full

Operating margin-40,856.3%+28,833pp

Net margin-39,009.5%+29,653pp

FCF margin-32,664.7%+4,018pp

Returns & leverage

See full

Return on equity-105.3%+50.6pp

Debt / equity0.2×0.0×

Where this comes from

Calculated from aTyr Pharma’s reported figures.

total current assets/total current liabilities=5.8×

Based on the most recent quarter.

The official record: aTyr Pharma’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about aTyr Pharma's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is aTyr Pharma's current ratio?: aTyr Pharma (ATYR) reported current ratio of 5.8× in Q1 2026.
How has aTyr Pharma's current ratio changed year-over-year?: aTyr Pharma's current ratio decreased by 25.9% year-over-year, from 7.8× to 5.8×.
What is the long-term trend for aTyr Pharma's current ratio?: Over 5 years (2020 to 2025), aTyr Pharma's current ratio has grown at a -2.7% compound annual growth rate (CAGR), from 6.1× to 5.3×.
What does current ratio mean?: Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.